Mizuho Securities Reiterates Buy on Questcor Pharmaceuticals on Stock Price Weakness
November 26, 2013 at 10:59 AM EST
In a report published Tuesday, Mizuho Securities USA analyst Mario Corso reiterated a Buy rating and $93.00 price target on Questcor Pharmaceuticals (NASDAQ: QCOR ). In the report, Mizuho Securities USA noted, “In the wake of today's stock price weakness on short report that FTC will challenge Synacthen deal, we
